Oncosem Announces 1,200% Bonus Share Capital Increase

Oncosem has decided to increase its paid-in capital by 1,200% through a bonus share issuance from internal resources. With this decision, the company aims to significantly expand its capital base. Following approval from the Capital Markets Board (SPK), the company's current capital of 23.85 million TL will rise to 310.05 million TL. This increase reflects the strength of the company's internal resources and its potential to create value for shareholders. The bonus share capital increase allows existing shareholders to acquire additional shares without any extra payment. This could enhance the company's market value and liquidity. This is not an investment recommendation.

📊 ONCSM — Piyasa Yorumu

▼ down · 65%

The stock has risen 6.8% in the last 24 hours, with its RSI reaching 81, entering overbought territory. The announcement of a 1200% bonus capital increase may create speculative short-term movement, but such news typically prices in as 'buy the rumor, sell the fact.' Technically overbought, the stock is likely to see profit-taking following the news. Although the MACD is positive, the overbought RSI and the potential that the bonus issue news has already been priced in suggest a short-term decline may be expected.

RSI 14

81.0

MACD

5.53

24h Δ

6.79%

Canlı Grafikler